This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Di Lieto, A. Articles by Staibano, S. Search for Related Content PubMed PubMed Citation Articles by Di Lieto, A. Articles by De Falco, M. Articles by Pollio, F. Articles by Mansueto, G. Articles by Salvatore, G. Articles by Somma, P. Articles by Ciociola, F. Articles by De Rosa, G. Articles by Staibano, S. Social Bookmarking                         What's this?

Clinical Response, Vascular Change, and Angiogenesis in Gonadotropin-Releasing Hormone Analogue-Treated Women with Uterine Myomas

Department of Obstetncal-Gynaecological and Urological Science and Reproductive Medicine; Department of Biomorphological and Functional Science, University "Fedenrco II" of Naples, Napoli, Italy; Via L. Giordano, 120, 80127 Napoli, Italy; dilieto{at}unina.it

Manianna De Falco, MD

Fabrizio Pollio, MD

Gelsomina Mansueto, MD

Gaetano Salvatore, MD

Pasquale Somma, MD

Francesca Ciociola, MD

Gaetano De Rosa, MD, PhD

Stefania Staibano, MD

Department of Obstetncal-Gynaecological and Urological Science and Reproductive Medicine; Department of Biomorphological and Functional Science, University "Fedenrco II" of Naples, Napoli, Italy.

Objective: Basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), and platelet-derived growth factor (PDGF) are involved in the pathogenesis of leiomyomas and influence angiogenesis, which is necessary for growth of leiomyomas. Gonadotropin-releasing hormone analogue (GnRH-a) treatment might modify the growth factor expression and the blood supply in myomas. We investigated the effects of GnRH-a treatment on some clinical parameters, on the immunohistochemical expression of bFGF, VEGF, and PDGF, and on the vasculature of leiomyomas.

Methods: Thirty-one women were treated with leuprolide acetate for 3 months; 55 untreated patients formed the control group. Hematologic parameters were assessed at the admission, after GnRH-a treatment, and after surgery. Uterine volume was evaluated by ultrasonography. The immunoexpression of bFGF, VEGF, and PDGF and of the endothelial markers CD34 and CD105, as well as the vascular pattern, were studied in leiomyomas, comparing treated and untreated patients.

Results: Hematologic parameters improved and uterine volumes decreased after GnRJH-a treatment. The immunoexpression of bFGF, VEGF, and PDGF decreased in treated myomas, together with the total number of vessels and the angiogenetic vessels.

Conclusion: This study confirms the clinical response of uterine shrinkage after GnRH-a treatment. A pathogenetic role of bFGF, VEGF, and PDGF in myoma growth and vascularization is suggested. Finally, this study indirectly confirms the importance of the vasculature in leiomyoma growth.

Key Words: Uterine leiomyomas • GnRH-a • angiogenesis • vasculature

Journal of the Society for Gynecologic Investigation, Vol. 12, No. 2, 123-128 (2005)
DOI: 10.1016/j.jsgi.2004.10.008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?